|
FY2026
12 months to May 31, 2026
|
FY2025
12 months to May 31, 2025
|
FY2024
12 months to May 31, 2024
|
FY2023
12 months to May 31, 2023
|
FY2022
12 months to May 31, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling, general and administrative | |||||
| Research and development costs | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income: | |||||
| Dividend, interest, and other income | |||||
| Unrealized holding gain on equity investment | |||||
| Total other income | |||||
| Loss before income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Other comprehensive loss, net of tax: | |||||
| Foreign currency translation adjustment | |||||
| Comprehensive loss | |||||
| Basic net loss per common share | |||||
| Diluted net loss per common share | |||||
| Weighted average number of common shares outstanding: | |||||
| Basic | |||||
| Diluted | |||||
Loading...